We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

4 hedge funds and large institutions have $13K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more capital invested

Capital invested by funds: $3K → $13K (+$10K)

100% more funds holding

Funds holding: 2 → 4 (+2)

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BO
BRR OpCo
Ohio
+$3K
2
FWM
Focused Wealth Management
New York
+$1K

Top Sellers

No sellers this quarter

PVCT Hedge Fund Activity: Q4 2017 in Review

4 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q4 2017, worth a combined $13K — up 333% from $3K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PVCT positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BRR OpCo, opening a new position worth an estimated $3K.

  • 4 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q4 2017, up from 2 in Q3 2017.
  • Funds reported $13K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q4 2017, up 333% quarter-over-quarter.
  • 2 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q4 2017 and 0 closed out, a net change of +2 holders.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q4 2017 was BRR OpCo, an estimated $3K added.

Based on aggregated 13F filings for Q4 2017.